| Period Ending | Dec 31, 2012 | Dec 31, 2011 | Dec 31, 2010 |
|---|
|
Total Revenue
|
277,984
|
286,608
|
280,157
| | Cost of Revenue | 154,540 | 163,211 | 159,832 | | |
Gross Profit
|
123,444
|
123,397
|
120,325
| |
|
Operating Expenses |
|
Research Development | 16,226 | 14,254 | 10,097 |
|
Selling General and Administrative | 127,606 | 118,680 | 99,012 |
|
Non Recurring |
-
|
-
|
-
|
|
Others |
-
|
-
|
-
|
|
|
|
Total Operating Expenses |
-
|
-
|
-
| | | |
Operating Income or Loss
|
(20,388)
|
(9,537)
|
11,216
| |
|
Income from Continuing Operations |
|
Total Other Income/Expenses Net | 1,457 | (987) | (85) |
|
Earnings Before Interest And Taxes | (18,931) | (10,524) | 11,131 |
|
Interest Expense | 1,591 | 1,053 | 718 |
|
Income Before Tax | (20,522) | (11,577) | 10,413 |
|
Income Tax Expense | 1,771 | 1,806 | 836 |
|
Minority Interest |
-
|
-
|
-
|
|
|
|
Net Income From Continuing Ops | (22,293) | (13,383) | 9,577 | |
|
Non-recurring Events |
|
Discontinued Operations |
-
|
-
|
-
|
|
Extraordinary Items |
-
|
-
|
-
|
|
Effect Of Accounting Changes |
-
|
-
|
-
|
|
Other Items |
-
|
-
|
-
| | | |
Net Income
|
(22,293)
|
(13,383)
|
9,577
| | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | |
Net Income Applicable To Common Shares
|
(22,293)
|
(13,383)
|
9,577
|
|